This book explores the transformative power of AI in the domain of neurodegenerative diseases such as ALS, Parkinson’s, and Alzheimer’s. It explores AI-driven advancements in predictive analytics, biomarker discovery, drug development, and rehabilitation tools while addressing ethical, regulatory, and data privacy challenges.